Investigation of mRNA expression of tumor necrosis factor-α, interleukin-1β, and cyclooxygenase-2 in cultured equine digital artery smooth muscle cells after exposure to endotoxin
- 1 December 2001
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 62 (12) , 1957-1963
- https://doi.org/10.2460/ajvr.2001.62.1957
Abstract
Objective—To determine messenger RNA expression of cyclooxygenase (COX)-2, tumor necrosis factor (TNF)-α, and interleukin- (IL)-1β from cultured equine smooth muscle cells (SMC).Sample Population—Segments of palmar digital artery harvested from 6 clinically normal adult horses.Procedure—Explants were collected from the tunica media of arteries for primary culture of SMC. Equine mononuclear cells were used as control cells. Subcultured vascular SMC and control cells were exposed to lipopolysaccharide (20 µg/ml and 100 ng/ml, respectively). Northern blot analysis with equine-specific probes for COX-2, TNF-α, and IL-1β was performed, using isolated total cellular RNA.Results—Although no message was detected for IL-1β or TNF-α in control or endotoxin-exposed equine vascular SMC from all horses, COX-2 underwent a distinct substantial up-regulation after endotoxin exposure. Endotoxin-exposed equine mononuclear cells had up-regulation of IL-1β and TNF-α mRNA.Conclusions and Clinical Relevance—Increased expression of COX-2 mRNA by equine vascular SMC may be an important early pathophysiologic event in the onset of endotoxemia in horses. Potentiated local vascular production of various prostanoids after increased expression of mRNA for COX-2 may result in vasoactive events observed with laminitis. (Am J Vet Res2001;62:1957–1963)Keywords
This publication has 31 references indexed in Scilit:
- Inhibition of release of tumor necrosis factor-alpha from human vascular tissue and smooth muscle cells by glucocorticoidsCritical Care Medicine, 1997
- Human blood vessels release tumor necrosis factor-alpha from a smooth muscle cell sourceCritical Care Medicine, 1996
- Interactions of endotoxin with human blood cells and serum proteinsScandinavian Journal of Clinical and Laboratory Investigation, 1996
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Both membrane‐bound and soluble forms of CD14 bind to Gram‐negative bacteriaEuropean Journal of Immunology, 1995
- Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissuesFEBS Letters, 1993
- Mediators of septic shockCritical Care Medicine, 1993
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Reactivity of Equine Palmar Digital Arteries and Veins to Vasodilating AgentsVeterinary Surgery, 1989
- Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.Journal of Clinical Investigation, 1988